Table 2.
Rate of Sexual Activitiesβ and Douching per 100 Days of Follow-Up (95% CI), Adjusting for Age Group
| Sexual Activity or Symptoms | Incident BV€ n=14 | No Incident BV€ N=22 | Relative Incidence | p-value* |
|---|---|---|---|---|
| Any sexual activity | 20.4 (16.4–25.5) | 14.6 (12.8–16.6) | 1.40 (1.08–1.81) | 0.010 |
| Sex with a woman | 14.3 (11.0–18.5) | 10.3 (8.9–12.0) | 1.38 (1.02–1.87) | 0.038 |
| Sex with a man | 3.4 (2.0–5.86) | 2.8 (2.0–3.8) | 1.23 (0.66–2.28) | 0.511 |
| Sex with a new female partner | 0.5 (0.2–1.38) | 0 | - | - |
| Sex with a new male partner | 1.3 (0.3–5.4) | 0.4 (0.2–0.8) | 3.71 (0.62–22.20) | 0.151 |
| Receptive oral sex | 8.1 (5.7–11.4) | 9.2 (7.8–10.8) | 0.88 (0.60–1.29) | 0.515 |
| Direct genital-genital contact | 3.9 (2.3–6.4) | 5.3 (4.2–6.5) | 0.73 (0.42–1.28) | 0.277 |
| Sex toy use | 3.5 (2.1–6.0) | 3.0 (2.3–4.0) | 1.17 (0.64–2.16) | 0.605 |
| Inconsistent dental dam use | 14.2 (11.0–18.5) | 11.3 (9.7–13.1) | 1.26 (0.93–1.71) | 0.132 |
| Inconsistent condom use | 2.1 (0.9–5.3) | 1.3 (0.8–2.0) | 1.65 (0.59–4.63) | 0.343 |
| Any digital-vaginal sex | 14.3 (11.0–18.7) | 9.1 (7.8–10.7) | 1.57 (1.15–2.15) | 0.005 |
| Any digital-anal sex | 2.9 (1.6–5.3) | 0.5 (0.3–1.0) | 5.56 (2.4–12.8) | <0.001 |
| Any finger or hand on vagina | 16.6 (13.0–21.1) | 12.4 (10.8–14.3) | 1.33 (1.00–1.77) | 0.048 |
| Douching** | 0 | 0.2 (0.1–0.7) | - | - |
| BV Symptoms | 3.4 (1.9–6.3) | 12.5 (10.9–14.3) | 0.27 (0.15–0.51) | <0.001 |
Sex with a female or male partner was defined as any oral, vaginal, and/or anal sexual contact. Direct genital-genital contact refers to the genital regions of each partner touching during sex (could be between two female sexual partners or female-male sexual partners). Sex toy use could include shared use however this data was not specifically captured. Data on vaginal insertion of sex toys or external use only was also not captured.
p-values calculated from a Poisson model adjusting for age group (<30, ≥30 years)
There were 428 days of follow-up in the incident BV group (mean, 30.6 days) and 1614 days of follow-up in the non-incident BV group (mean, 73.4 days).
Unadjusted estimates presented since the age-adjusted model would not converge.